Position in GSK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$542,022
-$116,339 QoQ
Shares Held
10,340
-13.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#464
of 1,032 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sivia Capital Partners, LLC holds $16,248,994 across 14 Drug Manufacturers - General names. GSK ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,555 | $4,263,974 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
47,373 | $2,729,632 | |
| 3 | MRK |
Merck & Co., Inc.
|
16,440 | $2,112,540 | |
| 4 | PFE |
Pfizer Inc
|
82,650 | $1,990,212 | |
| 5 | NVS |
Novartis AG
|
6,151 | $963,984 | |
| 6 | JNJ |
Johnson & Johnson
|
3,459 | $878,482 | |
| 7 | BIIB |
Biogen Inc.
|
3,879 | $838,096 | |
| 8 | GSK |
GSK plc
This page
|
10,340 | $542,022 |
All Filings in GSK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $542,022 | 10,340 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $658,361 | 11,929 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $835,151 | 17,030 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $569,064 | 13,185 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $257,356 | 6,702 | Shares | Sole | 2025-09-24 | |
| 2025-03-31 | $258,705 | 6,678 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $223,550 | 6,610 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $208,610 | 5,103 | Shares | Sole | 2024-10-11 | |
| 2024-03-31 | $219,065 | 5,110 | Shares | Sole | 2024-04-19 | |
| No filing history on record for this holder in this stock. | ||||||